<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang L</submitter><funding>NCRR NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>7859</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4532856</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6</volume><pubmed_abstract>Class B G protein-coupled receptors are composed of an extracellular domain (ECD) and a seven-transmembrane (7TM) domain, and their signalling is regulated by peptide hormones. Using a hybrid structural biology approach together with the ECD and 7TM domain crystal structures of the glucagon receptor (GCGR), we examine the relationship between full-length receptor conformation and peptide ligand binding. Molecular dynamics (MD) and disulfide crosslinking studies suggest that apo-GCGR can adopt both an open and closed conformation associated with extensive contacts between the ECD and 7TM domain. The electron microscopy (EM) map of the full-length GCGR shows how a monoclonal antibody stabilizes the ECD and 7TM domain in an elongated conformation. Hydrogen/deuterium exchange (HDX) studies and MD simulations indicate that an open conformation is also stabilized by peptide ligand binding. The combined studies reveal the open/closed states of GCGR and suggest that glucagon binds to GCGR by a conformational selection mechanism.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Conformational states of the full-length glucagon receptor.</pubmed_title><pmcid>PMC4532856</pmcid><funding_grant_id>S10 RR027270</funding_grant_id><funding_grant_id>U54 GM094618</funding_grant_id><funding_grant_id>P41 GM103310</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>de Graaf C</pubmed_authors><pubmed_authors>Reedtz-Runge S</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Carragher B</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Wang MW</pubmed_authors><pubmed_authors>Jiang H</pubmed_authors><pubmed_authors>Griffin PR</pubmed_authors><pubmed_authors>Wu B</pubmed_authors><pubmed_authors>Potter CS</pubmed_authors><pubmed_authors>Moeller A</pubmed_authors><pubmed_authors>Siu FY</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Song G</pubmed_authors><pubmed_authors>Dharmarajan V</pubmed_authors><pubmed_authors>Pascal BD</pubmed_authors><pubmed_authors>West GM</pubmed_authors><pubmed_authors>Zhou H</pubmed_authors><pubmed_authors>Stevens RC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Conformational states of the full-length glucagon receptor.</name><description>Class B G protein-coupled receptors are composed of an extracellular domain (ECD) and a seven-transmembrane (7TM) domain, and their signalling is regulated by peptide hormones. Using a hybrid structural biology approach together with the ECD and 7TM domain crystal structures of the glucagon receptor (GCGR), we examine the relationship between full-length receptor conformation and peptide ligand binding. Molecular dynamics (MD) and disulfide crosslinking studies suggest that apo-GCGR can adopt both an open and closed conformation associated with extensive contacts between the ECD and 7TM domain. The electron microscopy (EM) map of the full-length GCGR shows how a monoclonal antibody stabilizes the ECD and 7TM domain in an elongated conformation. Hydrogen/deuterium exchange (HDX) studies and MD simulations indicate that an open conformation is also stabilized by peptide ligand binding. The combined studies reveal the open/closed states of GCGR and suggest that glucagon binds to GCGR by a conformational selection mechanism.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jul</publication><modification>2024-11-12T15:03:35.472Z</modification><creation>2019-03-27T01:56:38Z</creation></dates><accession>S-EPMC4532856</accession><cross_references><pubmed>26227798</pubmed><doi>10.1038/ncomms8859</doi></cross_references></HashMap>